{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T04:22:14Z","timestamp":1648527734807},"reference-count":42,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.numecd.2011.02.004","type":"journal-article","created":{"date-parts":[[2011,5,21]],"date-time":"2011-05-21T03:26:52Z","timestamp":1305948412000},"page":"38-45","source":"Crossref","is-referenced-by-count":3,"title":["Partial normalization of components of metabolic syndrome does not influence prevalent echocardiographic abnormalities: The HyperGEN study"],"prefix":"10.1016","volume":"23","author":[{"given":"G.","family":"de Simone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.K.","family":"Arnett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Chinali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"De Marco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.C.","family":"Rao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.T.","family":"Kraja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.C.","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.B.","family":"Devereux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.numecd.2011.02.004_bib1","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/sj.jhh.1002203","article-title":"Clusters of metabolic risk factors predict cardiovascular events in hypertension with target-organ damage: the LIFE study","volume":"21","author":"de Simone","year":"2007","journal-title":"J Hum Hypertens"},{"key":"10.1016\/j.numecd.2011.02.004_bib2","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.numecd.2008.04.001","article-title":"Metabolic syndrome and left ventricular hypertrophy in the prediction of cardiovascular events: the strong heart study","volume":"19","author":"de Simone","year":"2009","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.numecd.2011.02.004_bib3","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1161\/01.CIR.88.4.1444","article-title":"Role of preclinical cardiovascular disease in the evolution from risk factor exposure to development of morbid events","volume":"88","author":"Devereux","year":"1993","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2011.02.004_bib4","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S1047-2797(00)00063-6","article-title":"NHLBI family blood pressure program: methodology and recruitment in the HyperGEN network. Hypertension genetic epidemiology network","volume":"10","author":"Williams","year":"2000","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.numecd.2011.02.004_bib5","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/00004872-200202000-00024","article-title":"Association of left ventricular hypertrophy with metabolic risk factors: the HyperGEN study","volume":"20","author":"de Simone","year":"2002","journal-title":"J Hypertens"},{"key":"10.1016\/j.numecd.2011.02.004_bib6","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2011.02.004_bib7","doi-asserted-by":"crossref","first-page":"51S","DOI":"10.1002\/j.1550-8528.1998.tb00690.x","article-title":"Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults \u2013 the evidence report. National Institutes of Health","volume":"6","year":"1998","journal-title":"Obes Res"},{"key":"10.1016\/j.numecd.2011.02.004_bib8","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/j.numecd.2011.02.004_bib9","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1161\/01.CIR.96.5.1416","article-title":"Relations of left ventricular mass to demographic and hemodynamic variables in American Indians: the strong heart study","volume":"96","author":"Devereux","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2011.02.004_bib10","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1161\/01.HYP.38.3.417","article-title":"Left ventricular systolic dysfunction in a biracial sample of hypertensive adults: the hypertension genetic epidemiology network (HyperGEN) study","volume":"38","author":"Devereux","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/j.numecd.2011.02.004_bib11","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1161\/01.CIR.58.6.1072","article-title":"Recommendations regarding quantitation in M-mode echocardiography: results of a survey of echocardiographic measurements","volume":"58","author":"Sahn","year":"1978","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2011.02.004_bib12","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/S0894-7317(89)80014-8","article-title":"Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American society of echocardiography committee on standards, subcommittee on quantitation of two-dimensional echocardiograms","volume":"2","author":"Schiller","year":"1989","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/j.numecd.2011.02.004_bib13","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0002-9149(86)90771-X","article-title":"Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings","volume":"57","author":"Devereux","year":"1986","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.numecd.2011.02.004_bib14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.amjhyper.2004.08.032","article-title":"Normalization for body size and population-attributable risk of left ventricular hypertrophy the strong heart study","volume":"18","author":"de Simone","year":"2005","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.numecd.2011.02.004_bib15","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1067\/mhj.2001.113218","article-title":"Prognostic implications of left ventricular hypertrophy","volume":"141","author":"Vakili","year":"2001","journal-title":"Am Heart J"},{"key":"10.1016\/j.numecd.2011.02.004_bib16","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/01.HYP.0000121223.44837.de","article-title":"Left ventricular concentric geometry during treatment adversely affects cardiovascular prognosis in hypertensive patients","volume":"43","author":"Muiesan","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/j.numecd.2011.02.004_bib17","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1001\/archinte.165.15.1788","article-title":"Left atrium size and the risk of cardiovascular death in middle-aged men","volume":"165","author":"Laukkanen","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.numecd.2011.02.004_bib18","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/j.ahj.2005.04.031","article-title":"Left atrial diameter as an independent predictor of first clinical cardiovascular events in middle-aged and elderly adults: the strong heart study (SHS)","volume":"151","author":"Kizer","year":"2006","journal-title":"Am Heart J"},{"key":"10.1016\/j.numecd.2011.02.004_bib19","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/0002-8703(90)90168-W","article-title":"Comparative accuracy of Doppler echocardiographic methods for clinical stroke volume determination","volume":"120","author":"Dubin","year":"1990","journal-title":"Am Heart J"},{"key":"10.1016\/j.numecd.2011.02.004_bib20","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S0002-9149(96)00425-0","article-title":"Estimation of left ventricular chamber and stroke volume by limited M-mode echocardiography and validation by two-dimensional and Doppler echocardiography","volume":"78","author":"de Simone","year":"1996","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.numecd.2011.02.004_bib21","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/0735-1097(94)90390-5","article-title":"Assessment of left ventricular function by the midwall fractional shortening\/end-systolic stress relation in human hypertension","volume":"23","author":"de Simone","year":"1994","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2011.02.004_bib22","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1161\/01.CIR.93.2.259","article-title":"Midwall left ventricular mechanics. An independent predictor of cardiovascular risk in arterial hypertension","volume":"93","author":"de Simone","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2011.02.004_bib23","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.amjhyper.2005.01.005","article-title":"Left atrial systolic force and cardiac markers of preclinical disease in hypertensive patients: the hypertension genetic epidemiology network (HyperGEN) study","volume":"18","author":"Chinali","year":"2005","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.numecd.2011.02.004_bib24","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1016\/j.amjhyper.2005.05.036","article-title":"Left atrial systolic force and cardiovascular outcome the strong heart study","volume":"18","author":"Chinali","year":"2005","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.numecd.2011.02.004_bib25","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.amjcard.2003.09.009","article-title":"Comparison of cardiac structure and function in American Indians with and without the metabolic syndrome (the strong heart study)","volume":"93","author":"Chinali","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.numecd.2011.02.004_bib26","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1161\/01.CIR.101.19.2271","article-title":"Impact of diabetes on cardiac structure and function: the strong heart study","volume":"101","author":"Devereux","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2011.02.004_bib27","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1161\/01.CIR.100.17.1802","article-title":"Circulating insulin and insulin growth factor-1 are independent determinants of left ventricular mass and geometry in essential hypertension","volume":"100","author":"Verdecchia","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2011.02.004_bib28","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/j.numecd.2008.12.012","article-title":"Clustered metabolic abnormalities blunt regression of hypertensive left ventricular hypertrophy: the LIFE study","volume":"19","author":"de Simone","year":"2009","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.numecd.2011.02.004_bib29","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.2337\/dc06-2152","article-title":"Prognostic impact of metabolic syndrome by different definitions in a population with high prevalence of obesity and diabetes: the strong heart study","volume":"30","author":"de Simone","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/j.numecd.2011.02.004_bib30","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.jacc.2005.12.046","article-title":"Metabolic syndrome and the risk of cardiovascular disease in older adults","volume":"47","author":"Butler","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2011.02.004_bib31","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.jacc.2008.04.013","article-title":"Cardiac markers of pre-clinical disease in adolescents with the metabolic syndrome: the strong heart study","volume":"52","author":"Chinali","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.numecd.2011.02.004_bib32","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1210\/jc.2006-0513","article-title":"Metabolic syndrome: a multiplex cardiovascular risk factor","volume":"92","author":"Grundy","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.numecd.2011.02.004_bib33","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1161\/01.HYP.0000251933.22091.24","article-title":"Metabolic syndrome in the Pressioni Arteriose Monitorate E Loro Associazioni (PAMELA) study: daily life blood pressure, cardiac damage, and prognosis","volume":"49","author":"Mancia","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.numecd.2011.02.004_bib34","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1161\/CIRCULATIONAHA.107.688788","article-title":"Burden and prognostic importance of subclinical cardiovascular disease in overweight and obese individuals","volume":"116","author":"Ingelsson","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.numecd.2011.02.004_bib35","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00019501-200602000-00013","article-title":"The metabolic syndrome: a call to action","volume":"17","author":"Gotto","year":"2006","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.numecd.2011.02.004_bib36","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1097\/HJH.0b013e3282ffdc80","article-title":"Factor relationships of metabolic syndrome and echocardiographic phenotypes in the HyperGEN study","volume":"26","author":"Huang","year":"2008","journal-title":"J Hypertens"},{"key":"10.1016\/j.numecd.2011.02.004_bib37","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1291\/hypres.29.897","article-title":"Left ventricular diastolic dysfunction as assessed by echocardiography in metabolic syndrome","volume":"29","author":"Masugata","year":"2006","journal-title":"Hypertens Res"},{"key":"10.1016\/j.numecd.2011.02.004_bib38","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.numecd.2005.03.005","article-title":"Influence of the metabolic syndrome on aortic stiffness in never treated hypertensive patients","volume":"16","author":"Mule","year":"2006","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.numecd.2011.02.004_bib39","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.amjhyper.2006.09.010","article-title":"Age and target organ damage in essential hypertension: role of the metabolic syndrome","volume":"20","author":"Cuspidi","year":"2007","journal-title":"Am J Hypertens"},{"issue":"Apr 19","key":"10.1016\/j.numecd.2011.02.004_bib40","doi-asserted-by":"crossref","first-page":"611","DOI":"10.7326\/0003-4819-142-8-200504190-00009","article-title":"The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the diabetes prevention program randomized trial","volume":"142","author":"Orchard","year":"2005","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.numecd.2011.02.004_bib41","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0140-6736(09)61457-4","article-title":"10-year follow-up of diabetes incidence and weight loss in the diabetes prevention program outcomes study","volume":"374","author":"Knowler","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.numecd.2011.02.004_bib42","doi-asserted-by":"crossref","first-page":"888","DOI":"10.2337\/diacare.28.4.888","article-title":"Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program","volume":"28","author":"Ratner","year":"2005","journal-title":"Diabetes Care"}],"container-title":["Nutrition, Metabolism and Cardiovascular Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475311000482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0939475311000482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T01:27:32Z","timestamp":1560216452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0939475311000482"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0939475311000482"],"URL":"https:\/\/doi.org\/10.1016\/j.numecd.2011.02.004","relation":{},"ISSN":["0939-4753"],"issn-type":[{"value":"0939-4753","type":"print"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}